Morgan Stanley maintains Figs Inc. as equal-weight, target down from $12 to $11
Based on the Figs stock forecast from 12 analysts, the average analyst target price for Figs Inc. is USD 21.16 over the next 12 months. Figs Inc.’s average analyst rating is Buy. Stock Target Advisor’s own stock analysis of Figs Inc. is Slightly Bearish, which is based on 6 positive signals and 9 negative signals. At the last closing, Figs Inc.’s stock price was USD 11.91. Figs Inc.’s stock price has changed by +0.15% over the past week, +2.13% over the past month and -67.17% over the last year.
About Figs Inc. (FIGS:NYE)
FIGS, Inc. is a healthcare apparel and lifestyle business that sells directly to consumers in the US. The company creates and markets medical uniforms as well as non-scrub products such lab coats, under scrubs, outerwear, activewear, loungewear, compression socks, and masks. Additionally, it sells performance leggings, tops, super-soft tops made of pima cotton, vests, and coats. The business uses its website and mobile app-based digital platform to market and sell its goods. Santa Monica, California serves as the corporate home of FIGS, Inc., which was established in 2013.
What we like:
The stock’s annual returns have been stable and consistent compared to its sector peers (for a hold period of at least 12 months) and are in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior return on assets
The company management has delivered a better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Positive cash flow
Figs stock forecast: The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What we don’t like:
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Poor risk-adjusted returns
Figs stock forecast: This company is delivering below median risk-adjusted returns to its peers. Even if it is outperforming on returns, the returns are unpredictable. Proceed with caution.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price-to-earnings basis and is above the sector median.
Overpriced compared to book value
The stock is trading high compared to its peers’ median on a price-to-book value basis.
Overpriced on a cash flow basis
Figs stock forecast: The stock is trading high compared to its peers on a price-to-cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering buying.
Poor return on equity
The company management has delivered below the median return on equity in the most recent 4 quarters compared to its peers.
Overpriced on a free cash flow basis
The stock is trading high compared to its peers on a price-to-free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering buying.
Low Earnings Growth
Figs stock forecast: This stock has shown below median earnings growth in the previous 5 years compared to its sector.
Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.